☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Accelerating the Transition Between Antibody Research and Production
June 7, 2022
GSK’s Priorix Receives the US FDA’s Approval for the Prevention of Measles, Mumps and Rubella in Patients Aged ≥12 Months
June 7, 2022
Eli Lilly Reports Results of Lebrikizumab in P-III (ADvocate 1 & 2) Trial for the Treatment of Atopic Dermatitis
June 7, 2022
Abbott Presents Results of Freestyle Libre 3 System for the Treatment of Type 1 or Type 2 Diabetes at ADA 2022
June 7, 2022
Amgen’s Riabni (biosimilar, rituximab) Receives the US FDA’s Approval for the Treatment of Rheumatoid Arthritis
June 7, 2022
BMS Reports Three and Five-Year Data of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III (CheckMate -9LA) and (CheckMate -227) Tr...
June 7, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions